GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Azitra AZTR · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.64

-12.08%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

—

FY2021FY2025

Net income

−$11.0m

FY2021FY2025

Free cash flow

−$11.4m

FY2021FY2025

Shareholders' equity

$3.8m

FY2021FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Revenue—$7,500$686,000$284,000$110,000
Gross profit−$453,144$7,500$686,000$284,000$110,000
Research and development$4.8m$4.7m$3.6m$6.1m$5.4m
Operating income−$11.0m−$11.0m−$7.5m−$9.5m−$9.2m
Net income−$11.0m−$9.0m−$11.3m−$10.7m−$8.9m
Diluted earnings per share-1.02-7.83-186.51-176.53-0.46

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Total assets$5.0m$7.4m$5.1m$7.2m$10.2m
Cash and short-term investments$2.1m$4.6m$1.8m$3.5m$8.0m
Total liabilities$1.2m$1.7m$2.2m$43.4m$36.0m
Debt$422,077$555,509$885,947$7.7m$992,019
Shareholders' equity$3.8m$5.7m$2.9m−$36.3m−$25.8m
Shares outstanding11m1m0m0m19m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Cash from operations−$11.2m−$10.2m−$7.4m−$8.3m−$8.1m
Capital spending−$186,062−$379,246−$318,259−$341,011−$652,275
Free cash flow−$11.4m−$10.6m−$7.7m−$8.7m−$8.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue——————$7.5m—
Gross profit—−$116,653−$113,104−$112,000−$110,622−$117,415−$115,748−$103,633
Operating income−$3.4m−$3.9m−$2.2m−$2.8m−$2.9m−$3.1m−$2.4m−$2.9m
Net income−$3.3m−$3.9m−$2.2m−$2.8m−$2.9m−$3.1m−$2.4m−$1.0m
Diluted earnings per share-0.17-0.20-0.21-0.26-0.27-0.29-2.09-0.88
Cash from operations−$3.0m−$2.0m−$2.0m−$2.0m−$2.0m−$3.0m−$2.0m−$2.0m
Total assets$8.9m$12.1m$5.0m$4.3m$4.0m$5.9m$7.4m$9.8m
Cash and short-term investments$6.7m$10.1m$2.1m$1.4m$1.0m$3.2m$4.6m$7.3m
Debt$359,055$246,590$265,887$580,298$303,353$254,103$271,243$292,526
Shareholders' equity$7.3m$10.5m$3.8m$2.3m$2.2m$4.4m$5.7m$8.1m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income5.1%——
Net income0.9%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023
Price to earnings-1.6-1.4-0.1
Price to sales——2.4

Share price return

Finished calendar years

202520242023
Return-82%-75%-74%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-to-1 reverse split · 26 Oct 2026
  • 6-to-1 reverse split · 21 Aug 2025
  • 30-to-1 reverse split · 1 Jul 2024

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.